US says remdesivir shows 'clear-cut' effect in treating coronavirus

Washington (AFP) – COVID-19 patients who took the antiviral remdesivir recovered about 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday, as the top US epidemiologist hailed the drug’s “clear-cut” benefit.The finding represents the first time any medication has been shown to improve outcomes against the COVID-19 illness, which has claimed more than 220,000 lives globally and brought the world economy to a grinding halt.The US National Institute of Allergy and Infectious Diseases (NIAID), which oversaw the trial, said that patients on the drug mad…

Read More

HEDGE accordingly